nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—ADRA2A—Apraclonidine—glaucoma	0.16	0.233	CbGbCtD
Dihydroergotamine—ADRA2A—Brimonidine—glaucoma	0.16	0.233	CbGbCtD
Dihydroergotamine—ADRA2A—Dipivefrin—glaucoma	0.128	0.186	CbGbCtD
Dihydroergotamine—ADRA2A—Clonidine—glaucoma	0.0666	0.0966	CbGbCtD
Dihydroergotamine—CYP3A4—Pilocarpine—glaucoma	0.0288	0.0418	CbGbCtD
Dihydroergotamine—ABCB1—Timolol—glaucoma	0.0277	0.0401	CbGbCtD
Dihydroergotamine—ABCB1—Clonidine—glaucoma	0.0235	0.0341	CbGbCtD
Dihydroergotamine—CYP3A4—Brinzolamide—glaucoma	0.0226	0.0328	CbGbCtD
Dihydroergotamine—CYP3A4—Dorzolamide—glaucoma	0.0219	0.0317	CbGbCtD
Dihydroergotamine—CYP3A4—Methazolamide—glaucoma	0.0195	0.0283	CbGbCtD
Dihydroergotamine—CYP3A4—Acetazolamide—glaucoma	0.0156	0.0226	CbGbCtD
Dihydroergotamine—CYP3A4—Clonidine—glaucoma	0.0141	0.0204	CbGbCtD
Dihydroergotamine—Anorexia—Pilocarpine—glaucoma	0.000277	0.000921	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Acetazolamide—glaucoma	0.000276	0.000919	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Apraclonidine—glaucoma	0.000276	0.000919	CcSEcCtD
Dihydroergotamine—Nervousness—Clonidine—glaucoma	0.000276	0.000918	CcSEcCtD
Dihydroergotamine—Paraesthesia—Dorzolamide—glaucoma	0.000276	0.000918	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000275	0.000916	CcSEcCtD
Dihydroergotamine—Pain—Brimonidine—glaucoma	0.000275	0.000916	CcSEcCtD
Dihydroergotamine—Dyspnoea—Dorzolamide—glaucoma	0.000274	0.000912	CcSEcCtD
Dihydroergotamine—Visual impairment—Betaxolol—glaucoma	0.000274	0.000911	CcSEcCtD
Dihydroergotamine—Insomnia—Brinzolamide—glaucoma	0.000273	0.000909	CcSEcCtD
Dihydroergotamine—Somnolence—Dorzolamide—glaucoma	0.000273	0.000909	CcSEcCtD
Dihydroergotamine—Muscle spasms—Clonidine—glaucoma	0.000273	0.000909	CcSEcCtD
Dihydroergotamine—Dyspnoea—Travoprost—glaucoma	0.000273	0.000908	CcSEcCtD
Dihydroergotamine—Hypotension—Pilocarpine—glaucoma	0.000271	0.000903	CcSEcCtD
Dihydroergotamine—Paraesthesia—Brinzolamide—glaucoma	0.000271	0.000903	CcSEcCtD
Dihydroergotamine—Dyspepsia—Dorzolamide—glaucoma	0.00027	0.0009	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Timolol—glaucoma	0.000269	0.000897	CcSEcCtD
Dihydroergotamine—Dyspnoea—Brinzolamide—glaucoma	0.000269	0.000896	CcSEcCtD
Dihydroergotamine—Dyspepsia—Travoprost—glaucoma	0.000269	0.000896	CcSEcCtD
Dihydroergotamine—Asthenia—Apraclonidine—glaucoma	0.000269	0.000895	CcSEcCtD
Dihydroergotamine—Somnolence—Brinzolamide—glaucoma	0.000268	0.000894	CcSEcCtD
Dihydroergotamine—Decreased appetite—Dorzolamide—glaucoma	0.000267	0.000889	CcSEcCtD
Dihydroergotamine—Urticaria—Acetazolamide—glaucoma	0.000266	0.000886	CcSEcCtD
Dihydroergotamine—Tremor—Clonidine—glaucoma	0.000266	0.000886	CcSEcCtD
Dihydroergotamine—Dyspepsia—Brinzolamide—glaucoma	0.000266	0.000885	CcSEcCtD
Dihydroergotamine—Pruritus—Apraclonidine—glaucoma	0.000265	0.000882	CcSEcCtD
Dihydroergotamine—Body temperature increased—Acetazolamide—glaucoma	0.000265	0.000882	CcSEcCtD
Dihydroergotamine—Fatigue—Dorzolamide—glaucoma	0.000265	0.000882	CcSEcCtD
Dihydroergotamine—Tinnitus—Betaxolol—glaucoma	0.000265	0.000882	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000264	0.00088	CcSEcCtD
Dihydroergotamine—Fatigue—Travoprost—glaucoma	0.000264	0.000878	CcSEcCtD
Dihydroergotamine—Flushing—Betaxolol—glaucoma	0.000264	0.000877	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Clonidine—glaucoma	0.000263	0.000877	CcSEcCtD
Dihydroergotamine—Pain—Dorzolamide—glaucoma	0.000263	0.000874	CcSEcCtD
Dihydroergotamine—Insomnia—Pilocarpine—glaucoma	0.000262	0.000874	CcSEcCtD
Dihydroergotamine—Decreased appetite—Brinzolamide—glaucoma	0.000262	0.000874	CcSEcCtD
Dihydroergotamine—Pain—Travoprost—glaucoma	0.000261	0.000871	CcSEcCtD
Dihydroergotamine—Agitation—Clonidine—glaucoma	0.000261	0.000869	CcSEcCtD
Dihydroergotamine—Paraesthesia—Pilocarpine—glaucoma	0.000261	0.000868	CcSEcCtD
Dihydroergotamine—Asthenia—Bimatoprost—glaucoma	0.000261	0.000867	CcSEcCtD
Dihydroergotamine—Fatigue—Brinzolamide—glaucoma	0.00026	0.000867	CcSEcCtD
Dihydroergotamine—Dyspnoea—Pilocarpine—glaucoma	0.000259	0.000861	CcSEcCtD
Dihydroergotamine—Pain—Brinzolamide—glaucoma	0.000258	0.00086	CcSEcCtD
Dihydroergotamine—Somnolence—Pilocarpine—glaucoma	0.000258	0.000859	CcSEcCtD
Dihydroergotamine—Pruritus—Bimatoprost—glaucoma	0.000257	0.000855	CcSEcCtD
Dihydroergotamine—Diarrhoea—Apraclonidine—glaucoma	0.000256	0.000853	CcSEcCtD
Dihydroergotamine—Malaise—Clonidine—glaucoma	0.000256	0.000853	CcSEcCtD
Dihydroergotamine—Dyspepsia—Pilocarpine—glaucoma	0.000255	0.00085	CcSEcCtD
Dihydroergotamine—Chills—Betaxolol—glaucoma	0.000255	0.000848	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Dorzolamide—glaucoma	0.000253	0.000843	CcSEcCtD
Dihydroergotamine—Decreased appetite—Pilocarpine—glaucoma	0.000252	0.00084	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Travoprost—glaucoma	0.000252	0.000839	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Timolol—glaucoma	0.000251	0.000836	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000251	0.000836	CcSEcCtD
Dihydroergotamine—Palpitations—Clonidine—glaucoma	0.000251	0.000835	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Travoprost—glaucoma	0.00025	0.000832	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Brinzolamide—glaucoma	0.000249	0.000828	CcSEcCtD
Dihydroergotamine—Pain—Pilocarpine—glaucoma	0.000248	0.000826	CcSEcCtD
Dihydroergotamine—Dizziness—Apraclonidine—glaucoma	0.000248	0.000825	CcSEcCtD
Dihydroergotamine—Urticaria—Dorzolamide—glaucoma	0.000244	0.000812	CcSEcCtD
Dihydroergotamine—Epistaxis—Timolol—glaucoma	0.000244	0.000812	CcSEcCtD
Dihydroergotamine—Abdominal pain—Dorzolamide—glaucoma	0.000243	0.000808	CcSEcCtD
Dihydroergotamine—Body temperature increased—Dorzolamide—glaucoma	0.000243	0.000808	CcSEcCtD
Dihydroergotamine—Tension—Betaxolol—glaucoma	0.000243	0.000808	CcSEcCtD
Dihydroergotamine—Sinusitis—Timolol—glaucoma	0.000242	0.000807	CcSEcCtD
Dihydroergotamine—Arthralgia—Clonidine—glaucoma	0.000242	0.000805	CcSEcCtD
Dihydroergotamine—Abdominal pain—Travoprost—glaucoma	0.000242	0.000805	CcSEcCtD
Dihydroergotamine—Anxiety—Clonidine—glaucoma	0.000241	0.000802	CcSEcCtD
Dihydroergotamine—Asthenia—Acetazolamide—glaucoma	0.00024	0.0008	CcSEcCtD
Dihydroergotamine—Dizziness—Bimatoprost—glaucoma	0.00024	0.0008	CcSEcCtD
Dihydroergotamine—Nervousness—Betaxolol—glaucoma	0.00024	0.000799	CcSEcCtD
Dihydroergotamine—Urticaria—Brinzolamide—glaucoma	0.00024	0.000799	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Pilocarpine—glaucoma	0.000239	0.000796	CcSEcCtD
Dihydroergotamine—Discomfort—Clonidine—glaucoma	0.000239	0.000795	CcSEcCtD
Dihydroergotamine—Vomiting—Apraclonidine—glaucoma	0.000238	0.000793	CcSEcCtD
Dihydroergotamine—Muscle spasms—Betaxolol—glaucoma	0.000238	0.000791	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000237	0.00079	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Brimonidine—glaucoma	0.000237	0.000789	CcSEcCtD
Dihydroergotamine—Dry mouth—Clonidine—glaucoma	0.000236	0.000787	CcSEcCtD
Dihydroergotamine—Dermatitis—Apraclonidine—glaucoma	0.000236	0.000786	CcSEcCtD
Dihydroergotamine—Headache—Apraclonidine—glaucoma	0.000235	0.000781	CcSEcCtD
Dihydroergotamine—Confusional state—Clonidine—glaucoma	0.000234	0.000778	CcSEcCtD
Dihydroergotamine—Rhinitis—Timolol—glaucoma	0.000233	0.000774	CcSEcCtD
Dihydroergotamine—Oedema—Clonidine—glaucoma	0.000232	0.000772	CcSEcCtD
Dihydroergotamine—Tremor—Betaxolol—glaucoma	0.000232	0.000771	CcSEcCtD
Dihydroergotamine—Asthenia—Brimonidine—glaucoma	0.000231	0.000768	CcSEcCtD
Dihydroergotamine—Abdominal pain—Pilocarpine—glaucoma	0.000229	0.000764	CcSEcCtD
Dihydroergotamine—Body temperature increased—Pilocarpine—glaucoma	0.000229	0.000764	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Betaxolol—glaucoma	0.000229	0.000764	CcSEcCtD
Dihydroergotamine—Diarrhoea—Acetazolamide—glaucoma	0.000229	0.000763	CcSEcCtD
Dihydroergotamine—Rash—Bimatoprost—glaucoma	0.000229	0.000762	CcSEcCtD
Dihydroergotamine—Dermatitis—Bimatoprost—glaucoma	0.000229	0.000762	CcSEcCtD
Dihydroergotamine—Shock—Clonidine—glaucoma	0.000228	0.000759	CcSEcCtD
Dihydroergotamine—Pruritus—Brimonidine—glaucoma	0.000228	0.000757	CcSEcCtD
Dihydroergotamine—Headache—Bimatoprost—glaucoma	0.000228	0.000757	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Dorzolamide—glaucoma	0.000226	0.000753	CcSEcCtD
Dihydroergotamine—Tachycardia—Clonidine—glaucoma	0.000226	0.000753	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Travoprost—glaucoma	0.000225	0.00075	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Clonidine—glaucoma	0.000224	0.000746	CcSEcCtD
Dihydroergotamine—Visual impairment—Timolol—glaucoma	0.000224	0.000744	CcSEcCtD
Dihydroergotamine—Malaise—Betaxolol—glaucoma	0.000223	0.000742	CcSEcCtD
Dihydroergotamine—Nausea—Apraclonidine—glaucoma	0.000222	0.000741	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Brinzolamide—glaucoma	0.000222	0.000741	CcSEcCtD
Dihydroergotamine—Vertigo—Betaxolol—glaucoma	0.000222	0.000739	CcSEcCtD
Dihydroergotamine—Dizziness—Acetazolamide—glaucoma	0.000222	0.000738	CcSEcCtD
Dihydroergotamine—Anorexia—Clonidine—glaucoma	0.000221	0.000735	CcSEcCtD
Dihydroergotamine—Asthenia—Dorzolamide—glaucoma	0.00022	0.000734	CcSEcCtD
Dihydroergotamine—Asthenia—Travoprost—glaucoma	0.000219	0.00073	CcSEcCtD
Dihydroergotamine—Palpitations—Betaxolol—glaucoma	0.000218	0.000727	CcSEcCtD
Dihydroergotamine—Pruritus—Dorzolamide—glaucoma	0.000217	0.000723	CcSEcCtD
Dihydroergotamine—Asthenia—Brinzolamide—glaucoma	0.000217	0.000721	CcSEcCtD
Dihydroergotamine—Hypotension—Clonidine—glaucoma	0.000217	0.000721	CcSEcCtD
Dihydroergotamine—Pruritus—Travoprost—glaucoma	0.000216	0.00072	CcSEcCtD
Dihydroergotamine—Tinnitus—Timolol—glaucoma	0.000216	0.00072	CcSEcCtD
Dihydroergotamine—Nausea—Bimatoprost—glaucoma	0.000216	0.000718	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Pilocarpine—glaucoma	0.000214	0.000712	CcSEcCtD
Dihydroergotamine—Pruritus—Brinzolamide—glaucoma	0.000214	0.000711	CcSEcCtD
Dihydroergotamine—Vomiting—Acetazolamide—glaucoma	0.000213	0.000709	CcSEcCtD
Dihydroergotamine—Dizziness—Brimonidine—glaucoma	0.000213	0.000708	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000211	0.000703	CcSEcCtD
Dihydroergotamine—Arthralgia—Betaxolol—glaucoma	0.00021	0.000701	CcSEcCtD
Dihydroergotamine—Myalgia—Betaxolol—glaucoma	0.00021	0.000701	CcSEcCtD
Dihydroergotamine—Diarrhoea—Dorzolamide—glaucoma	0.00021	0.0007	CcSEcCtD
Dihydroergotamine—Headache—Acetazolamide—glaucoma	0.00021	0.000699	CcSEcCtD
Dihydroergotamine—Anxiety—Betaxolol—glaucoma	0.00021	0.000698	CcSEcCtD
Dihydroergotamine—Insomnia—Clonidine—glaucoma	0.00021	0.000698	CcSEcCtD
Dihydroergotamine—Diarrhoea—Travoprost—glaucoma	0.000209	0.000697	CcSEcCtD
Dihydroergotamine—Asthenia—Pilocarpine—glaucoma	0.000208	0.000693	CcSEcCtD
Dihydroergotamine—Paraesthesia—Clonidine—glaucoma	0.000208	0.000693	CcSEcCtD
Dihydroergotamine—Discomfort—Betaxolol—glaucoma	0.000208	0.000692	CcSEcCtD
Dihydroergotamine—Dyspnoea—Clonidine—glaucoma	0.000207	0.000688	CcSEcCtD
Dihydroergotamine—Diarrhoea—Brinzolamide—glaucoma	0.000207	0.000688	CcSEcCtD
Dihydroergotamine—Somnolence—Clonidine—glaucoma	0.000206	0.000686	CcSEcCtD
Dihydroergotamine—Dry mouth—Betaxolol—glaucoma	0.000206	0.000685	CcSEcCtD
Dihydroergotamine—Pruritus—Pilocarpine—glaucoma	0.000205	0.000684	CcSEcCtD
Dihydroergotamine—Confusional state—Betaxolol—glaucoma	0.000203	0.000677	CcSEcCtD
Dihydroergotamine—Dizziness—Dorzolamide—glaucoma	0.000203	0.000676	CcSEcCtD
Dihydroergotamine—Rash—Brimonidine—glaucoma	0.000203	0.000675	CcSEcCtD
Dihydroergotamine—Dermatitis—Brimonidine—glaucoma	0.000203	0.000674	CcSEcCtD
Dihydroergotamine—Dizziness—Travoprost—glaucoma	0.000202	0.000673	CcSEcCtD
Dihydroergotamine—Oedema—Betaxolol—glaucoma	0.000202	0.000672	CcSEcCtD
Dihydroergotamine—Headache—Brimonidine—glaucoma	0.000201	0.000671	CcSEcCtD
Dihydroergotamine—Decreased appetite—Clonidine—glaucoma	0.000201	0.000671	CcSEcCtD
Dihydroergotamine—Fatigue—Clonidine—glaucoma	0.0002	0.000665	CcSEcCtD
Dihydroergotamine—Dizziness—Brinzolamide—glaucoma	0.0002	0.000665	CcSEcCtD
Dihydroergotamine—Nausea—Acetazolamide—glaucoma	0.000199	0.000663	CcSEcCtD
Dihydroergotamine—Diarrhoea—Pilocarpine—glaucoma	0.000199	0.000661	CcSEcCtD
Dihydroergotamine—Shock—Betaxolol—glaucoma	0.000198	0.000661	CcSEcCtD
Dihydroergotamine—Tension—Timolol—glaucoma	0.000198	0.00066	CcSEcCtD
Dihydroergotamine—Pain—Clonidine—glaucoma	0.000198	0.00066	CcSEcCtD
Dihydroergotamine—Tachycardia—Betaxolol—glaucoma	0.000197	0.000656	CcSEcCtD
Dihydroergotamine—Nervousness—Timolol—glaucoma	0.000196	0.000653	CcSEcCtD
Dihydroergotamine—Vomiting—Dorzolamide—glaucoma	0.000195	0.00065	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Betaxolol—glaucoma	0.000195	0.000649	CcSEcCtD
Dihydroergotamine—Rash—Dorzolamide—glaucoma	0.000194	0.000645	CcSEcCtD
Dihydroergotamine—Dermatitis—Dorzolamide—glaucoma	0.000193	0.000644	CcSEcCtD
Dihydroergotamine—Rash—Travoprost—glaucoma	0.000193	0.000642	CcSEcCtD
Dihydroergotamine—Dermatitis—Travoprost—glaucoma	0.000193	0.000641	CcSEcCtD
Dihydroergotamine—Headache—Dorzolamide—glaucoma	0.000192	0.000641	CcSEcCtD
Dihydroergotamine—Anorexia—Betaxolol—glaucoma	0.000192	0.00064	CcSEcCtD
Dihydroergotamine—Vomiting—Brinzolamide—glaucoma	0.000192	0.000639	CcSEcCtD
Dihydroergotamine—Dizziness—Pilocarpine—glaucoma	0.000192	0.000639	CcSEcCtD
Dihydroergotamine—Headache—Travoprost—glaucoma	0.000192	0.000638	CcSEcCtD
Dihydroergotamine—Nausea—Brimonidine—glaucoma	0.000191	0.000636	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Clonidine—glaucoma	0.000191	0.000636	CcSEcCtD
Dihydroergotamine—Rash—Brinzolamide—glaucoma	0.00019	0.000634	CcSEcCtD
Dihydroergotamine—Dermatitis—Brinzolamide—glaucoma	0.00019	0.000633	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Clonidine—glaucoma	0.000189	0.000631	CcSEcCtD
Dihydroergotamine—Headache—Brinzolamide—glaucoma	0.000189	0.00063	CcSEcCtD
Dihydroergotamine—Hypotension—Betaxolol—glaucoma	0.000189	0.000628	CcSEcCtD
Dihydroergotamine—Vomiting—Pilocarpine—glaucoma	0.000185	0.000614	CcSEcCtD
Dihydroergotamine—Urticaria—Clonidine—glaucoma	0.000184	0.000613	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000184	0.000612	CcSEcCtD
Dihydroergotamine—Abdominal pain—Clonidine—glaucoma	0.000183	0.00061	CcSEcCtD
Dihydroergotamine—Body temperature increased—Clonidine—glaucoma	0.000183	0.00061	CcSEcCtD
Dihydroergotamine—Rash—Pilocarpine—glaucoma	0.000183	0.000609	CcSEcCtD
Dihydroergotamine—Dermatitis—Pilocarpine—glaucoma	0.000183	0.000609	CcSEcCtD
Dihydroergotamine—Insomnia—Betaxolol—glaucoma	0.000182	0.000608	CcSEcCtD
Dihydroergotamine—Nausea—Dorzolamide—glaucoma	0.000182	0.000607	CcSEcCtD
Dihydroergotamine—Headache—Pilocarpine—glaucoma	0.000182	0.000605	CcSEcCtD
Dihydroergotamine—Nausea—Travoprost—glaucoma	0.000182	0.000605	CcSEcCtD
Dihydroergotamine—Vertigo—Timolol—glaucoma	0.000181	0.000604	CcSEcCtD
Dihydroergotamine—Paraesthesia—Betaxolol—glaucoma	0.000181	0.000603	CcSEcCtD
Dihydroergotamine—Dyspnoea—Betaxolol—glaucoma	0.00018	0.000599	CcSEcCtD
Dihydroergotamine—Nausea—Brinzolamide—glaucoma	0.000179	0.000597	CcSEcCtD
Dihydroergotamine—Palpitations—Timolol—glaucoma	0.000178	0.000594	CcSEcCtD
Dihydroergotamine—Dyspepsia—Betaxolol—glaucoma	0.000178	0.000591	CcSEcCtD
Dihydroergotamine—Decreased appetite—Betaxolol—glaucoma	0.000175	0.000584	CcSEcCtD
Dihydroergotamine—Hypertension—Timolol—glaucoma	0.000174	0.00058	CcSEcCtD
Dihydroergotamine—Fatigue—Betaxolol—glaucoma	0.000174	0.000579	CcSEcCtD
Dihydroergotamine—Pain—Betaxolol—glaucoma	0.000173	0.000574	CcSEcCtD
Dihydroergotamine—Nausea—Pilocarpine—glaucoma	0.000172	0.000574	CcSEcCtD
Dihydroergotamine—Myalgia—Timolol—glaucoma	0.000172	0.000572	CcSEcCtD
Dihydroergotamine—Arthralgia—Timolol—glaucoma	0.000172	0.000572	CcSEcCtD
Dihydroergotamine—Anxiety—Timolol—glaucoma	0.000171	0.00057	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Clonidine—glaucoma	0.000171	0.000568	CcSEcCtD
Dihydroergotamine—Discomfort—Timolol—glaucoma	0.00017	0.000566	CcSEcCtD
Dihydroergotamine—Dry mouth—Timolol—glaucoma	0.000168	0.00056	CcSEcCtD
Dihydroergotamine—Asthenia—Clonidine—glaucoma	0.000166	0.000554	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Betaxolol—glaucoma	0.000166	0.000554	CcSEcCtD
Dihydroergotamine—Confusional state—Timolol—glaucoma	0.000166	0.000553	CcSEcCtD
Dihydroergotamine—Oedema—Timolol—glaucoma	0.000165	0.000549	CcSEcCtD
Dihydroergotamine—Pruritus—Clonidine—glaucoma	0.000164	0.000546	CcSEcCtD
Dihydroergotamine—Shock—Timolol—glaucoma	0.000162	0.00054	CcSEcCtD
Dihydroergotamine—Urticaria—Betaxolol—glaucoma	0.00016	0.000534	CcSEcCtD
Dihydroergotamine—Body temperature increased—Betaxolol—glaucoma	0.000159	0.000531	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Timolol—glaucoma	0.000159	0.00053	CcSEcCtD
Dihydroergotamine—Diarrhoea—Clonidine—glaucoma	0.000159	0.000528	CcSEcCtD
Dihydroergotamine—Anorexia—Timolol—glaucoma	0.000157	0.000523	CcSEcCtD
Dihydroergotamine—Hypotension—Timolol—glaucoma	0.000154	0.000513	CcSEcCtD
Dihydroergotamine—Dizziness—Clonidine—glaucoma	0.000153	0.00051	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Timolol—glaucoma	0.00015	0.0005	CcSEcCtD
Dihydroergotamine—Insomnia—Timolol—glaucoma	0.000149	0.000496	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Betaxolol—glaucoma	0.000149	0.000495	CcSEcCtD
Dihydroergotamine—Paraesthesia—Timolol—glaucoma	0.000148	0.000493	CcSEcCtD
Dihydroergotamine—Vomiting—Clonidine—glaucoma	0.000147	0.000491	CcSEcCtD
Dihydroergotamine—Dyspnoea—Timolol—glaucoma	0.000147	0.000489	CcSEcCtD
Dihydroergotamine—Somnolence—Timolol—glaucoma	0.000147	0.000488	CcSEcCtD
Dihydroergotamine—Rash—Clonidine—glaucoma	0.000146	0.000486	CcSEcCtD
Dihydroergotamine—Dermatitis—Clonidine—glaucoma	0.000146	0.000486	CcSEcCtD
Dihydroergotamine—Headache—Clonidine—glaucoma	0.000145	0.000483	CcSEcCtD
Dihydroergotamine—Dyspepsia—Timolol—glaucoma	0.000145	0.000483	CcSEcCtD
Dihydroergotamine—Asthenia—Betaxolol—glaucoma	0.000145	0.000482	CcSEcCtD
Dihydroergotamine—Decreased appetite—Timolol—glaucoma	0.000143	0.000477	CcSEcCtD
Dihydroergotamine—Pruritus—Betaxolol—glaucoma	0.000143	0.000475	CcSEcCtD
Dihydroergotamine—Fatigue—Timolol—glaucoma	0.000142	0.000473	CcSEcCtD
Dihydroergotamine—Pain—Timolol—glaucoma	0.000141	0.000469	CcSEcCtD
Dihydroergotamine—Diarrhoea—Betaxolol—glaucoma	0.000138	0.00046	CcSEcCtD
Dihydroergotamine—Nausea—Clonidine—glaucoma	0.000138	0.000458	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Timolol—glaucoma	0.000136	0.000452	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Timolol—glaucoma	0.000135	0.000449	CcSEcCtD
Dihydroergotamine—Dizziness—Betaxolol—glaucoma	0.000133	0.000444	CcSEcCtD
Dihydroergotamine—Urticaria—Timolol—glaucoma	0.000131	0.000436	CcSEcCtD
Dihydroergotamine—Abdominal pain—Timolol—glaucoma	0.00013	0.000434	CcSEcCtD
Dihydroergotamine—Body temperature increased—Timolol—glaucoma	0.00013	0.000434	CcSEcCtD
Dihydroergotamine—Vomiting—Betaxolol—glaucoma	0.000128	0.000427	CcSEcCtD
Dihydroergotamine—Rash—Betaxolol—glaucoma	0.000127	0.000424	CcSEcCtD
Dihydroergotamine—Dermatitis—Betaxolol—glaucoma	0.000127	0.000423	CcSEcCtD
Dihydroergotamine—Headache—Betaxolol—glaucoma	0.000126	0.000421	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Timolol—glaucoma	0.000121	0.000404	CcSEcCtD
Dihydroergotamine—Nausea—Betaxolol—glaucoma	0.00012	0.000399	CcSEcCtD
Dihydroergotamine—Asthenia—Timolol—glaucoma	0.000118	0.000394	CcSEcCtD
Dihydroergotamine—Pruritus—Timolol—glaucoma	0.000117	0.000388	CcSEcCtD
Dihydroergotamine—Diarrhoea—Timolol—glaucoma	0.000113	0.000375	CcSEcCtD
Dihydroergotamine—Dizziness—Timolol—glaucoma	0.000109	0.000363	CcSEcCtD
Dihydroergotamine—Vomiting—Timolol—glaucoma	0.000105	0.000349	CcSEcCtD
Dihydroergotamine—Rash—Timolol—glaucoma	0.000104	0.000346	CcSEcCtD
Dihydroergotamine—Dermatitis—Timolol—glaucoma	0.000104	0.000346	CcSEcCtD
Dihydroergotamine—Headache—Timolol—glaucoma	0.000103	0.000344	CcSEcCtD
Dihydroergotamine—Nausea—Timolol—glaucoma	9.79e-05	0.000326	CcSEcCtD
Dihydroergotamine—HTR2B—GPCR ligand binding—EDN1—glaucoma	2e-05	0.00198	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—PTGFR—glaucoma	2e-05	0.00198	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—PTGFR—glaucoma	1.99e-05	0.00196	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—PTGFR—glaucoma	1.97e-05	0.00195	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	1.95e-05	0.00192	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—PTGFR—glaucoma	1.95e-05	0.00192	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—SMO—glaucoma	1.94e-05	0.00191	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—C3—glaucoma	1.92e-05	0.00189	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—C3—glaucoma	1.9e-05	0.00188	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HEYL—glaucoma	1.89e-05	0.00186	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—LRP12—glaucoma	1.87e-05	0.00184	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.86e-05	0.00184	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—C3—glaucoma	1.86e-05	0.00184	CbGpPWpGaD
Dihydroergotamine—ADRA2A—G alpha (i) signalling events—C3—glaucoma	1.84e-05	0.00182	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PTGFR—glaucoma	1.83e-05	0.0018	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	1.8e-05	0.00177	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.79e-05	0.00177	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	1.78e-05	0.00176	CbGpPWpGaD
Dihydroergotamine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	1.77e-05	0.00174	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—C3—glaucoma	1.75e-05	0.00173	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—SMO—glaucoma	1.71e-05	0.00169	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Platelet activation, signaling and aggregation—FN1—glaucoma	1.7e-05	0.00168	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—SMO—glaucoma	1.7e-05	0.00167	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.68e-05	0.00165	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.67e-05	0.00164	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—TGFB2—glaucoma	1.66e-05	0.00164	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—SMO—glaucoma	1.66e-05	0.00164	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—OPN4—glaucoma	1.65e-05	0.00162	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.64e-05	0.00161	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—EDN1—glaucoma	1.63e-05	0.0016	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—RPTOR—glaucoma	1.57e-05	0.00155	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—SMO—glaucoma	1.56e-05	0.00154	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—RPTOR—glaucoma	1.56e-05	0.00153	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—VEGFA—glaucoma	1.53e-05	0.00151	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HEYL—glaucoma	1.53e-05	0.00151	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	1.53e-05	0.00151	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—RPTOR—glaucoma	1.52e-05	0.0015	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NCK2—glaucoma	1.52e-05	0.0015	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NCK2—glaucoma	1.51e-05	0.00149	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PTGFR—glaucoma	1.48e-05	0.00146	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NCK2—glaucoma	1.47e-05	0.00145	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.47e-05	0.00145	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CA1—glaucoma	1.44e-05	0.00142	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—RPTOR—glaucoma	1.43e-05	0.00141	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.43e-05	0.00141	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—C3—glaucoma	1.42e-05	0.0014	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.41e-05	0.00139	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—TNF—glaucoma	1.4e-05	0.00138	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CTSA—glaucoma	1.39e-05	0.00137	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NCK2—glaucoma	1.39e-05	0.00137	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CA2—glaucoma	1.32e-05	0.0013	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—TNF—glaucoma	1.31e-05	0.0013	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.31e-05	0.00129	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—OPN4—glaucoma	1.29e-05	0.00128	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HDAC9—glaucoma	1.29e-05	0.00127	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HDAC9—glaucoma	1.28e-05	0.00126	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—EDN1—glaucoma	1.28e-05	0.00126	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—SMO—glaucoma	1.27e-05	0.00125	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—SOD1—glaucoma	1.26e-05	0.00124	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CA5A—glaucoma	1.26e-05	0.00124	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—NARFL—glaucoma	1.26e-05	0.00124	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HDAC9—glaucoma	1.25e-05	0.00124	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—EDN1—glaucoma	1.24e-05	0.00122	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—EDN1—glaucoma	1.23e-05	0.00121	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.22e-05	0.0012	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—EDN1—glaucoma	1.21e-05	0.00119	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HEYL—glaucoma	1.2e-05	0.00119	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HDAC9—glaucoma	1.18e-05	0.00116	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PTGFR—glaucoma	1.17e-05	0.00115	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—RPTOR—glaucoma	1.16e-05	0.00114	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.14e-05	0.00113	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—EDN1—glaucoma	1.13e-05	0.00112	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—EDN1—glaucoma	1.13e-05	0.00111	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.13e-05	0.00111	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NCK2—glaucoma	1.12e-05	0.00111	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—EDN1—glaucoma	1.12e-05	0.0011	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—C3—glaucoma	1.12e-05	0.0011	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—EDN1—glaucoma	1.1e-05	0.00108	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—C3—glaucoma	1.08e-05	0.00107	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—C3—glaucoma	1.08e-05	0.00106	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—C3—glaucoma	1.05e-05	0.00104	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—EDN1—glaucoma	1.03e-05	0.00101	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—SMO—glaucoma	1.01e-05	0.000996	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—SMO—glaucoma	1e-05	0.000988	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CA1—glaucoma	9.95e-06	0.000981	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—SMO—glaucoma	9.95e-06	0.000981	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—C3—glaucoma	9.9e-06	0.000976	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—C3—glaucoma	9.85e-06	0.000971	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—SMO—glaucoma	9.81e-06	0.000968	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—C3—glaucoma	9.77e-06	0.000964	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	9.73e-06	0.00096	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CTSA—glaucoma	9.64e-06	0.00095	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—MMP1—glaucoma	9.6e-06	0.000947	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	9.6e-06	0.000947	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—C3—glaucoma	9.57e-06	0.000944	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HDAC9—glaucoma	9.55e-06	0.000942	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—TXN—glaucoma	9.27e-06	0.000914	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NTRK2—glaucoma	9.24e-06	0.000911	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—SMO—glaucoma	9.22e-06	0.000909	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—CAV1—glaucoma	9.21e-06	0.000908	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—EDN1—glaucoma	9.19e-06	0.000906	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NTRK2—glaucoma	9.17e-06	0.000904	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—RPTOR—glaucoma	9.12e-06	0.000899	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CA2—glaucoma	9.1e-06	0.000897	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	9.09e-06	0.000897	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—C3—glaucoma	8.99e-06	0.000886	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NTRK2—glaucoma	8.97e-06	0.000885	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NCK2—glaucoma	8.83e-06	0.000871	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—FN1—glaucoma	8.76e-06	0.000864	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NTRK2—glaucoma	8.43e-06	0.000832	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—EDN1—glaucoma	8.34e-06	0.000823	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—C3—glaucoma	8.03e-06	0.000792	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NGFR—glaucoma	7.92e-06	0.000782	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NGFR—glaucoma	7.86e-06	0.000776	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NGFR—glaucoma	7.7e-06	0.000759	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	7.56e-06	0.000746	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NTRK1—glaucoma	7.53e-06	0.000743	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HDAC9—glaucoma	7.51e-06	0.000741	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—SMO—glaucoma	7.48e-06	0.000737	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NTRK1—glaucoma	7.47e-06	0.000737	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NTRK1—glaucoma	7.32e-06	0.000722	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—C3—glaucoma	7.29e-06	0.000719	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NGFR—glaucoma	7.23e-06	0.000713	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	7.22e-06	0.000712	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—GSTT1—glaucoma	7.19e-06	0.000709	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—NOS3—glaucoma	6.96e-06	0.000687	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CDKN2B—glaucoma	6.94e-06	0.000684	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CDKN2B—glaucoma	6.89e-06	0.000679	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NTRK1—glaucoma	6.87e-06	0.000678	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NTRK2—glaucoma	6.84e-06	0.000674	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CDKN2B—glaucoma	6.74e-06	0.000665	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—EDN1—glaucoma	6.66e-06	0.000657	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—EDN1—glaucoma	6.61e-06	0.000652	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—EDN1—glaucoma	6.56e-06	0.000647	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	6.48e-06	0.000639	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—EDN1—glaucoma	6.47e-06	0.000638	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—TXN—glaucoma	6.41e-06	0.000632	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CDKN2B—glaucoma	6.33e-06	0.000625	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—C3—glaucoma	6.31e-06	0.000622	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CA1—glaucoma	6.13e-06	0.000605	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NGF—glaucoma	6.12e-06	0.000603	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—EDN1—glaucoma	6.08e-06	0.000599	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NGF—glaucoma	6.07e-06	0.000599	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NGF—glaucoma	5.95e-06	0.000586	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CTSA—glaucoma	5.94e-06	0.000586	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—SMO—glaucoma	5.88e-06	0.000579	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NGFR—glaucoma	5.87e-06	0.000579	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—C3—glaucoma	5.82e-06	0.000574	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—C3—glaucoma	5.77e-06	0.000569	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—C3—glaucoma	5.73e-06	0.000565	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—ABCA1—glaucoma	5.73e-06	0.000565	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CYP1B1—glaucoma	5.73e-06	0.000565	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	5.71e-06	0.000563	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—C3—glaucoma	5.65e-06	0.000557	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CA2—glaucoma	5.61e-06	0.000553	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NGF—glaucoma	5.58e-06	0.000551	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NTRK1—glaucoma	5.57e-06	0.00055	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—APOE—glaucoma	5.41e-06	0.000534	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NTRK2—glaucoma	5.37e-06	0.00053	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—APOE—glaucoma	5.37e-06	0.00053	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CAV1—glaucoma	5.36e-06	0.000529	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CAV1—glaucoma	5.32e-06	0.000525	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—C3—glaucoma	5.31e-06	0.000524	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—APOE—glaucoma	5.26e-06	0.000519	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CAV1—glaucoma	5.21e-06	0.000514	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CDKN2B—glaucoma	5.14e-06	0.000507	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—FN1—glaucoma	5.11e-06	0.000504	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—FN1—glaucoma	5.07e-06	0.0005	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—BAD—glaucoma	5.05e-06	0.000498	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—VEGFA—glaucoma	5.02e-06	0.000495	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—BAD—glaucoma	5.01e-06	0.000494	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—GSTT1—glaucoma	4.97e-06	0.00049	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—FN1—glaucoma	4.96e-06	0.000489	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—APOE—glaucoma	4.94e-06	0.000487	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—EDN1—glaucoma	4.93e-06	0.000486	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—BAD—glaucoma	4.9e-06	0.000484	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CAV1—glaucoma	4.9e-06	0.000483	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—FN1—glaucoma	4.66e-06	0.00046	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NGFR—glaucoma	4.61e-06	0.000455	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—BAD—glaucoma	4.61e-06	0.000454	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—GSTM1—glaucoma	4.58e-06	0.000452	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NGF—glaucoma	4.53e-06	0.000447	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NTRK1—glaucoma	4.38e-06	0.000432	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—C3—glaucoma	4.31e-06	0.000425	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NOS3—glaucoma	4.06e-06	0.0004	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—MTHFR—glaucoma	4.05e-06	0.000399	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	4.04e-06	0.000398	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NOS3—glaucoma	4.03e-06	0.000397	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—APOE—glaucoma	4.01e-06	0.000395	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CAV1—glaucoma	3.97e-06	0.000392	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ABCA1—glaucoma	3.96e-06	0.000391	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CYP1B1—glaucoma	3.96e-06	0.000391	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—TXN—glaucoma	3.95e-06	0.00039	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NOS3—glaucoma	3.94e-06	0.000389	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—EDN1—glaucoma	3.87e-06	0.000382	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—TP53—glaucoma	3.79e-06	0.000374	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—FN1—glaucoma	3.78e-06	0.000373	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—APOE—glaucoma	3.77e-06	0.000372	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—BAD—glaucoma	3.74e-06	0.000368	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CAV1—glaucoma	3.73e-06	0.000368	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NOS3—glaucoma	3.7e-06	0.000365	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NGF—glaucoma	3.56e-06	0.000351	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CDKN1B—glaucoma	3.51e-06	0.000347	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CDKN1B—glaucoma	3.49e-06	0.000344	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CDKN1B—glaucoma	3.41e-06	0.000337	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—C3—glaucoma	3.38e-06	0.000334	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—MMP9—glaucoma	3.25e-06	0.000321	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—MMP9—glaucoma	3.23e-06	0.000319	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CDKN1B—glaucoma	3.21e-06	0.000316	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—GSTM1—glaucoma	3.17e-06	0.000312	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—MMP9—glaucoma	3.16e-06	0.000312	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—APOE—glaucoma	3.15e-06	0.000311	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CAV1—glaucoma	3.12e-06	0.000308	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GSTT1—glaucoma	3.06e-06	0.000302	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NOS3—glaucoma	3e-06	0.000296	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—MMP9—glaucoma	2.97e-06	0.000293	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—FN1—glaucoma	2.97e-06	0.000293	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—BAD—glaucoma	2.94e-06	0.00029	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—VEGFA—glaucoma	2.92e-06	0.000288	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—VEGFA—glaucoma	2.9e-06	0.000286	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—VEGFA—glaucoma	2.84e-06	0.00028	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—NOS3—glaucoma	2.82e-06	0.000278	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—MTHFR—glaucoma	2.8e-06	0.000276	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—VEGFA—glaucoma	2.67e-06	0.000263	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—APOE—glaucoma	2.61e-06	0.000257	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CDKN1B—glaucoma	2.6e-06	0.000257	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PTGS2—glaucoma	2.58e-06	0.000255	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CAV1—glaucoma	2.58e-06	0.000255	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CYP1B1—glaucoma	2.44e-06	0.000241	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ABCA1—glaucoma	2.44e-06	0.000241	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—MMP9—glaucoma	2.41e-06	0.000238	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NOS3—glaucoma	2.36e-06	0.000233	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TP53—glaucoma	2.21e-06	0.000218	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TP53—glaucoma	2.19e-06	0.000216	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—VEGFA—glaucoma	2.16e-06	0.000213	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TP53—glaucoma	2.15e-06	0.000212	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	2.04e-06	0.000202	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TP53—glaucoma	2.02e-06	0.000199	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—NOS3—glaucoma	1.95e-06	0.000193	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GSTM1—glaucoma	1.95e-06	0.000192	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—MMP9—glaucoma	1.89e-06	0.000187	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PTGS2—glaucoma	1.79e-06	0.000176	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—MTHFR—glaucoma	1.72e-06	0.00017	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—VEGFA—glaucoma	1.7e-06	0.000168	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TP53—glaucoma	1.63e-06	0.000161	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—APOE—glaucoma	1.61e-06	0.000158	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CAV1—glaucoma	1.59e-06	0.000157	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TP53—glaucoma	1.28e-06	0.000127	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—NOS3—glaucoma	1.2e-06	0.000119	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PTGS2—glaucoma	1.1e-06	0.000108	CbGpPWpGaD
